TMEM192 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.410400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.252400E-01
Normal-vs-Stage2
1.471960E-01
Normal-vs-Stage3
2.264300E-02
Normal-vs-Stage4
8.890200E-01
Stage1-vs-Stage2
2.144200E-01
Stage1-vs-Stage3
1.030170E-02
Stage1-vs-Stage4
6.396400E-01
Stage2-vs-Stage3
3.641500E-03
Stage2-vs-Stage4
1.413160E-01
Stage3-vs-Stage4
6.410300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.462800E-01
Normal-vs-AfricanAmerican
7.567600E-01
Normal-vs-Asian
5.648300E-02
Caucasian-vs-AfricanAmerican
2.388800E-01
Caucasian-vs-Asian
2.238600E-01
AfricanAmerican-vs-Asian
4.738200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.343800E-01
Normal-vs-Female
2.701400E-01
Male-vs-Female
4.698200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.589000E-01
Normal-vs-Age(41-60Yrs)
4.020800E-01
Normal-vs-Age(61-80Yrs)
2.007200E-01
Normal-vs-Age(81-100Yrs)
1.538620E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.081000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.143800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.489000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.018200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.389000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.957400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.419600E-02
Normal-vs-Daily Drinker
7.936400E-02
Normal-vs-Weekly Drinker
1.663390E-01
Normal-vs-Occasional Drinker
2.620400E-01
Normal-vs-Social Drinker
7.851200E-01
Non Drinker-vs-Daily Drinker
9.511600E-01
Non Drinker-vs-Weekly Drinker
5.545200E-01
Non Drinker-vs-Occasional Drinker
2.273400E-01
Non Drinker-vs-Social Drinker
1.288590E-01
Daily Drinker-vs-Weekly Drinker
6.604600E-01
Daily Drinker-vs-Occasional Drinker
3.403800E-01
Daily Drinker-vs-Social Drinker
1.493010E-01
Weekly Drinker-vs-Occasional Drinker
6.681400E-01
Weekly Drinker-vs-Social Drinker
2.645000E-01
Occasional Drinker-vs-Social Drinker
3.995200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.184790E-01
Normal-vs-Grade 2
1.750290E-02
Normal-vs-Grade 3
3.575600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.100800E-01
Grade 1-vs-Grade 3
6.828400E-01
Grade 1-vs-Grade 4
1.184790E-01
Grade 2-vs-Grade 3
3.085600E-01
Grade 2-vs-Grade 4
1.750290E-02
Grade 3-vs-Grade 4
3.575600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.130000E-01
Normal-vs-NonDiabetic
2.417400E-01
Diabetic-vs-NonDiabetic
7.212200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.556400E-02
Normal-vs-NoPancreatitis
2.310200E-01
Pancreatitis-vs-NoPancreatitis
5.339600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.450000E-01
Normal-vs-N1
1.602420E-01
N0-vs-N1
3.795800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.888600E-01
Normal-vs-TP53-NonMutant
7.499800E-01
TP53-Mutant-vs-TP53-NonMutant
6.952200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
